Results 231 to 240 of about 3,323,629 (269)
Some of the next articles are maybe not open access.
Embodied masculinity and androgen deprivation therapy
Sociology of Health and Illness, 2006This paper describes the findings from an ethnographic study of 16 Anglo-Australian men treated with androgen deprivation therapy (ADT) for advanced prostate cancer. Utilising a social constructionist gendered analysis, participants' experiences, particularly in relation to embodied masculinity, are described in the context of reduced testosterone that
openaire +2 more sources
Complications of Androgen-Deprivation Therapy for Prostate Cancer
Clinical Prostate Cancer, 2003Androgen deprivation as a form of treatment for prostate cancer has been used for decades. Within the last decade, however, there has been a significant increase in its use. Therefore, it is incumbent upon the physician to be familiar with the side effects associated with this treatment.Some of the side effects such as osteoporosis, changes in lipid ...
Jeffrey M, Holzbeierlein +2 more
openaire +3 more sources
2010
Androgen deprivation therapy (ADT) is the upfront systemic therapy for advanced prostate cancer. ADT is administered medically or through surgical castration, and it suppresses serum testosterone levels. Furthermore, ADT may be given alone or in combination with an androgen receptor antagonist.
openaire +1 more source
Androgen deprivation therapy (ADT) is the upfront systemic therapy for advanced prostate cancer. ADT is administered medically or through surgical castration, and it suppresses serum testosterone levels. Furthermore, ADT may be given alone or in combination with an androgen receptor antagonist.
openaire +1 more source
Androgen Deprivation Therapy Cardiotoxicity
2021The patient is a 63-year-old male, case of metastatic castrate-sensitive prostate cancer on goserelin injections every 3 month. Given his initial Gleason1 grade of 8, as well as doubling Prostate-specific antigen, (PSA) in 7 months since starting treatment, he was started on androgen receptor inhibitor, apalutamide.
openaire +1 more source
Complications of androgen deprivation therapy in prostate cancer
Current Opinion in Urology, 2009To review the current data on adverse effects of androgen deprivation therapy for prostate cancer and to discuss some considerations when choosing therapy and managing side-effects.Despite the existing data supporting the use of androgen deprivation therapy in prostate cancer patients, several questions regarding timing, survival benefit and impact in ...
Anita, Schwandt, Jorge A, Garcia
openaire +2 more sources
Androgen deprivation therapy: past, present and future
BJU International, 2012Since Huggins and Hodges demonstrated the responsiveness of prostate cancer to androgen deprivation therapy (ADT), androgen‐suppressing strategies have formed the cornerstone of management of advanced prostate cancer. Approaches to ADT have included orchidectomy, oestrogens, luteinizing hormone‐releasing hormone (LHRH) agonists, anti‐androgens and more
F, Schröder +4 more
openaire +2 more sources
Pitfalls of Androgen Deprivation Therapy
2012Androgen deprivation therapy (ADT) is a widely used method of treatment for men with prostate cancer. In men with metastatic disease, primary ADT improves quality of life and extends overall survival. ADT improves both progression free and overall survival in men with intermediate and high risk early stage disease.
Alicia K. Morgans, Matthew R. Smith
openaire +1 more source

